11 providers to share data on 1.1M patients for diabetes registry

Network - 37.55 Kb
Eleven integrated health systems have combined de-identified data from their EHRs to form a private-sector diabetes registry.

The SUPREME-DM (SUrveillance, PREvention, and ManageEment of Diabetes Mellitus) DataLink includes de-identified health information from nearly 1.1 million people with diabetes in 10 states: California, Colorado, Georgia, Hawaii, Michigan, Minnesota, Oregon, Pennsylvania, Washington and Wisconsin.

Participating health plans include six regions of Kaiser Permanente, Geisinger Health System, Group Health Cooperative, HealthPartners, Henry Ford Health System and Marshfield Clinic.

The DataLink contains test results, prescription records, hospital and clinic visit information and vital statistics. According to a study published in the Centers for Disease Control and Prevention's (CDC) "Preventing Chronic Disease," the SUPREME-DM DataLink provides a resource to conduct population-based diabetes research and clinical trials, allowing users to compare prevention and treatment strategies.

“The database contains an ethnically and geographically diverse population of women and men who mirror the general population with diabetes,” noted John F. Steiner, MD, MPH, senior director with the Kaiser Permanente Institute for Health Research in Denver, in a prepared statement. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.